Radicicol

DB03758

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 364.777
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

41 Data
Acetaminophen The serum concentration of Acetaminophen can be increased when it is combined with Radicicol.
Propacetamol The serum concentration of Propacetamol can be increased when it is combined with Radicicol.
Salmon calcitonin The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Radicicol.
Thyrotropin alfa The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Radicicol.
Follitropin The therapeutic efficacy of Follitropin can be decreased when used in combination with Radicicol.
Liothyronine The therapeutic efficacy of Liothyronine can be decreased when used in combination with Radicicol.
Carbimazole The therapeutic efficacy of Carbimazole can be decreased when used in combination with Radicicol.
Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Radicicol.
Propylthiouracil The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Radicicol.
Methimazole The therapeutic efficacy of Methimazole can be decreased when used in combination with Radicicol.
Liotrix The therapeutic efficacy of Liotrix can be decreased when used in combination with Radicicol.
3,5-Diiodotyrosine The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Radicicol.
Tiratricol The therapeutic efficacy of Tiratricol can be decreased when used in combination with Radicicol.
Parathyroid hormone The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Radicicol.
Teriparatide The therapeutic efficacy of Teriparatide can be decreased when used in combination with Radicicol.
Potassium Iodide The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Radicicol.
Dibromotyrosine The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Radicicol.
Thyroid, porcine The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Radicicol.
Potassium perchlorate The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Radicicol.
Protirelin The therapeutic efficacy of Protirelin can be decreased when used in combination with Radicicol.
3,5-diiodothyropropionic acid The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with Radicicol.
Methylthiouracil The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Radicicol.
Elcatonin The therapeutic efficacy of Elcatonin can be decreased when used in combination with Radicicol.
Benzylthiouracil The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Radicicol.
Thyrotropin The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Radicicol.
Dicoumarol The therapeutic efficacy of Dicoumarol can be increased when used in combination with Radicicol.
Phenindione The therapeutic efficacy of Phenindione can be increased when used in combination with Radicicol.
Warfarin The therapeutic efficacy of Warfarin can be increased when used in combination with Radicicol.
Phenprocoumon The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Radicicol.
Acenocoumarol The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Radicicol.
4-hydroxycoumarin The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Radicicol.
Coumarin The therapeutic efficacy of Coumarin can be increased when used in combination with Radicicol.
(R)-warfarin The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Radicicol.
Ethyl biscoumacetate The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Radicicol.
Fluindione The therapeutic efficacy of Fluindione can be increased when used in combination with Radicicol.
Clorindione The therapeutic efficacy of Clorindione can be increased when used in combination with Radicicol.
Diphenadione The therapeutic efficacy of Diphenadione can be increased when used in combination with Radicicol.
Tioclomarol The therapeutic efficacy of Tioclomarol can be increased when used in combination with Radicicol.
(S)-Warfarin The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Radicicol.
Voriconazole The serum concentration of Radicicol can be increased when it is combined with Voriconazole.
Palopegteriparatide The therapeutic efficacy of Palopegteriparatide can be decreased when used in combination with Radicicol.

Target Protein

Heat shock protein HSP 90-alpha HSP90AA1
Heat shock protein HSP 90-beta HSP90AB1
Endoplasmin HSP90B1
Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial DLAT
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial PDK3
Virulence sensor histidine kinase PhoQ phoQ

Referensi & Sumber

Synthesis reference: Yukio Sugimura, Kimio Iino, Yoshio Tsujita, Yoko Shimada, Tomowo Kobayashi, Takeshi Kagasaki, "Radicicol derivatives, their preparation and their anti-tumor activity." U.S. Patent US5597846, issued September, 1979.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul